Correlation Between Eledon Pharmaceuticals and Carmell Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Carmell Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Carmell Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eledon Pharmaceuticals and Carmell Therapeutics, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Carmell Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Carmell Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Carmell Therapeutics.

Diversification Opportunities for Eledon Pharmaceuticals and Carmell Therapeutics

-0.61
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Eledon and Carmell is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Carmell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Carmell Therapeutics and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Carmell Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Carmell Therapeutics has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Carmell Therapeutics go up and down completely randomly.

Pair Corralation between Eledon Pharmaceuticals and Carmell Therapeutics

Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to generate 0.72 times more return on investment than Carmell Therapeutics. However, Eledon Pharmaceuticals is 1.39 times less risky than Carmell Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Carmell Therapeutics is currently generating about -0.09 per unit of risk. If you would invest  419.00  in Eledon Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  7.00  from holding Eledon Pharmaceuticals or generate 1.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Eledon Pharmaceuticals  vs.  Carmell Therapeutics

 Performance 
       Timeline  
Eledon Pharmaceuticals 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very unsteady fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.
Carmell Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Carmell Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Eledon Pharmaceuticals and Carmell Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eledon Pharmaceuticals and Carmell Therapeutics

The main advantage of trading using opposite Eledon Pharmaceuticals and Carmell Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Carmell Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Carmell Therapeutics will offset losses from the drop in Carmell Therapeutics' long position.
The idea behind Eledon Pharmaceuticals and Carmell Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Content Syndication
Quickly integrate customizable finance content to your own investment portal